Citigroup’s Acurx Pharmaceuticals ACXP Stock Holding History

Citigroup’s Portfolio ACXP Stock Details ACXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4	Hold	1	–	–	﹤0.01%	5784
2025 Q4	$2	Sell	1 -452	-100%	-$2.17K	﹤0.01%	5917
2025 Q3	$1.94K	Buy	+453	New	+$2.73K	﹤0.01%	5494

Other funds holding ACXP

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

PFS

Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Citigroup's ACXP Position: Q1 2026 in Review

Citigroup held its Acurx Pharmaceuticals (ACXP) position steady in Q1 2026 at 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #5784.

Citigroup first reported a position in ACXP in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.94K in Q3 2025. 21 funds tracked by Wall St. Rank hold ACXP as of Q1 2026.

Citigroup held 1 share of Acurx Pharmaceuticals worth $4 as of Q1 2026.
Citigroup left its Acurx Pharmaceuticals share count unchanged in Q1 2026.
Acurx Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5784 holding.
Citigroup first reported a position in Acurx Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
Citigroup's Acurx Pharmaceuticals position peaked at $1.94K in Q3 2025.
21 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.